Group 1 - The company Beijing Zhongguancun Technology Development (Holding) Co., Ltd. has a subsidiary, Beijing Zhongshi New Materials Co., Ltd., which has filed a lawsuit against China State Construction Engineering Corporation due to a sales contract dispute [3][4] - The total amount involved in the lawsuit is RMB 6,447,914.59 [2][7] - The lawsuit is currently in the acceptance stage by the court and has not yet been heard [1][8] Group 2 - The plaintiff, Zhongshi New Materials, claims that the defendant owes RMB 10,245,884.84 for concrete supplied under a contract for a hospital construction project, of which RMB 5,287,867.76 remains unpaid [4][5] - The lawsuit requests the defendant to pay the outstanding amount and overdue interest, totaling RMB 6,447,914.59 [6][7] - The court has scheduled the hearing for August 2025 [3][4] Group 3 - The company has disclosed that there are no other undisclosed litigation or arbitration matters [7] - The impact of the lawsuit on the company's current or future profits is currently indeterminate [2][8] - The company will continue to monitor the lawsuit's progress and will disclose information as required by law [8] Group 4 - Another subsidiary, Shandong Huasu Pharmaceutical Co., Ltd., has obtained a utility model patent certificate from the National Intellectual Property Administration [10][11] - The patent is effective for ten years from the date of application and is expected to enhance the company's intellectual property protection and innovation capabilities [11][12]

证券日报网讯 7月30日晚间，中关村发布公告称，近日，公司下属公司山东华素制药有限公司取得国家 知识产权局颁发的实用新型专利证书。 （文章来源：证券日报） ...

Group 1 - The core point of the article is that Zhongguancun announced the acquisition of a utility model patent for a sodium sulfanilate preparation mixing device by its subsidiary, Shandong Huasu Pharmaceutical Co., Ltd. [2] - In the fiscal year 2024, Zhongguancun's revenue composition is as follows: 74.96% from biomedicine, 17.48% from concrete, 4.94% from elderly health, and 2.62% from other sectors [2]

证券代码：000931 证券简称：中关村 公告编号：2025-076 北京中关村科技发展（控股）股份有限公司 关于下属公司山东华素取得实用新型专利证书的公告 关于下属公司山东华素取得实用新型专利证书的公告 共 1 页 注：专利权自授权公告之日起生效。专利权期限为十年，自申请日起算。 上述实用新型专利不会对公司近期生产经营产生重大影响，但有利于进一步 完善公司知识产权保护体系，充分发挥自主知识产权优势，促进技术创新，形成 持续创新机制，提升公司的综合竞争力。敬请广大投资者注意投资风险。 备查文件 1、国家知识产权局颁发的实用新型专利证书。 特此公告 北京中关村科技发展（控股）股份有限公司 董 事 会 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 近日，北京中关村科技发展（控股）股份有限公司（以下简称：公司）下属 公司山东华素制药有限公司取得国家知识产权局颁发的实用新型专利证书，具体 情况如下： | 实用新型名称 | 专利申请日 | | | | 授权公告日 | | | 专利号 | 授权公告号 | 专利权人 | | --- | --- | --- | --- | ...

关于下属公司提起诉讼的公告 共 3 页 证券代码：000931 证券简称：中关村 公告编号：2025-075 北京中关村科技发展（控股）股份有限公司 关于下属公司提起诉讼的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、案件所处的诉讼阶段：法院已受理，尚未开庭审理。 2、上市公司所处的当事人地位：原告为公司下属公司。 3、涉案的金额：总金额人民币 6,447,914.59 元。 4、对上市公司损益产生的影响：目前案件尚未开庭审理，其对公司本期利 润或期后利润的影响暂时无法判断。 一、本次诉讼事项受理的基本情况 北京中关村科技发展（控股）股份有限公司（以下简称：公司）控股子公司 北京中实混凝土有限责任公司之控股子公司北京中实新材料有限责任公司（以下 简称：中实新材料）向北京市丰台区人民法院递交《民事起诉状》，因买卖合同 纠纷起诉中国建筑一局（集团）有限公司，北京市丰台区人民法院已受理本案， 收到北京市丰台区人民法院《传票》【（2025）京 0106 民初 37635 号】，该案 件将于 2025 年 8 月开庭审理。 中实新材料与被告就北京 ...

Core Viewpoint - The healthcare industry is recognized as a strategic emerging industry in China, facing financing challenges due to long R&D cycles and high investment requirements, prompting Beijing Zhongguancun Bank to develop specialized financial services to support innovation in this sector [1][2][3]. Industry Overview - The healthcare sector is experiencing unprecedented growth driven by factors such as an aging population, increased health awareness, and technological breakthroughs. The Beijing Municipal Government aims for the pharmaceutical and healthcare industry to reach a total scale of 1.25 trillion yuan by 2026 [2]. - The average R&D cycle for innovative drugs is 5-8 years, requiring investments of hundreds of millions to billions of yuan, with a success rate of less than 10%. High-end medical devices also face lengthy commercialization processes, leading to significant financing challenges for companies [2][3]. Company Strategy - Beijing Zhongguancun Bank has focused on the healthcare sector since its establishment in 2017, creating a comprehensive service system to address financing pain points and support industry upgrades [1][4]. - The bank has developed a specialized team with backgrounds in medicine, pharmacy, and bioengineering to enhance credit assessment and review processes [4][5]. Financial Solutions - The bank has introduced innovative financial products tailored to the healthcare sector, such as a "Technology R&D Loan" with a maximum term of 5 years and a "Warrant Loan" that combines debt financing with equity options to mitigate risks [8]. - A proprietary evaluation model has been developed, incorporating AI technology to assess healthcare companies based on their pipeline value, financing health, competitive landscape, and commercialization prospects [7][8]. Ecosystem Development - The bank aims to transform from a mere fund provider to a long-term partner for healthcare companies by building a "financial + ecosystem" service model, collaborating with various stakeholders including investment institutions, hospitals, and research institutions [9][10]. - The bank has supported over 300 healthcare companies in Beijing, with more than 200 receiving credit support totaling nearly 5 billion yuan, with 30% being first-time borrowers [5][10].

登录新浪财经APP 搜索【信披】查看更多考评等级 近日，公司向银行查询获悉被冻结的银行账户资金已全部解除冻结，现将相关情况公告如下： 一、本次银行账户资金解除冻结情况 公司与托普天空出具书面《确认书》，经福州中院核算恢复执行金额，双方一致确认以3,063,145.02元 了结此案，即托普天空在收到法院发放的上述金额后此案执行完毕结案。公司已向福州中院支付执行款 项共计3,063,145.02元，被冻结的银行账户资金已全部解除冻结，具体情况如下： ■ 二、对公司的影响 证券代码：000931 证券简称：中关村 公告编号：2025-074 北京中关村科技发展（控股）股份有限公司 关于公司部分银行账户资金解除冻结的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 北京中关村科技发展（控股）股份有限公司（以下简称：公司）于2025年6月20日披露《关于公司部分 银行账户资金被冻结的公告》（公告编号：2025-066），因北京托普天空科技有限公司（以下简称：托 普天空）与福州华电房地产公司、公司委托贷款合同纠纷一案，托普天空向福建省福州市中级人民法院 （以下简称：福 ...

近日，公司向银行查询获悉被冻结的银行账户资金已全部解除冻结，现将 相关情况公告如下： 一、本次银行账户资金解除冻结情况 公司与托普天空出具书面《确认书》，经福州中院核算恢复执行金额，双 方一致确认以 3,063,145.02 元了结此案，即托普天空在收到法院发放的上述金 额后此案执行完毕结案。公司已向福州中院支付执行款项共计 3,063,145.02 元， 被冻结的银行账户资金已全部解除冻结，具体情况如下： 账户 解除冻结金 证券代码：000931 证券简称：中关村 公告编号：2025-074 北京中关村科技发展（控股）股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 北京中关村科技发展（控股）股份有限公司（以下简称：公司）于 2025 年 电房地产公司、公司委托贷款合同纠纷一案，托普天空向福建省福州市中级人 民法院（以下简称：福州中院）申请恢复执行。福州中院冻结公司部分银行账 户资金，冻结金额共计 2,352,030.70 元。 性质 额（元） 公司发布的信息以在指定信息披露媒体《中国证券报》《证券时报》《证 券日报》《上海证券报》和巨潮资讯网刊 ...

证券日报网讯 7月29日晚间，中关村发布公告称，近日，公司向银行查询获悉被冻结的银行账户资金已 全部解除冻结。 （文章来源：证券日报） ...

Group 1 - The forum focused on the theme "AI + City: A New Era of Data" and aimed to promote the integration of AI technology with urban development through practical applications and innovative data infrastructure [1][2] - Key topics discussed included the application of AI in smart city governance, the construction of new data infrastructure, and the release of data element value mechanisms [1][2] - Notable speakers included academicians who presented reports on the role of AI and IoT in enhancing smart city development [1][2] Group 2 - Various companies shared their innovative explorations and experiences, including Guanglun Intelligent, Zhongke Zidong Taichu, and Qianxingyu Company, focusing on simulation and synthetic data [2] - The forum announced the launch of the "AI Panorama Empowerment Action Plan" for 2024, which will feature 44 typical cases across ten fields, including AI for services and healthcare [2][3] - The forum highlighted the release of intelligent agent products and trusted data space products, which support efficient data circulation and urban governance [3][4] Group 3 - Collaborations were formed between various organizations, including a partnership between Data Group and Beijing University of Posts and Telecommunications to establish a joint laboratory for smart city innovation [4] - Agreements were made to create benchmarks for urban digital transformation and to promote talent exchange in the field of smart cities [4] - The forum initiated an intelligent agent ecosystem cooperation plan involving 24 organizations to enhance collaborative applications and technology transfer [4]